414PDPhase I study of the CTLA-4 inhibitor MK-1308 in combination with pembrolizumab in patients with advanced solid tumors. (23rd October 2018)

Record Type:: Journal Article
Title:: 414PDPhase I study of the CTLA-4 inhibitor MK-1308 in combination with pembrolizumab in patients with advanced solid tumors. (23rd October 2018)
Main Title:: 414PDPhase I study of the CTLA-4 inhibitor MK-1308 in combination with pembrolizumab in patients with advanced solid tumors
Authors:: Cho, B C
Perets, R
Bar, J
Ahn, M-J
Kim, D-W
Yoh, K
Nagrial, A
Spigel, D R
Lee, D H
Gutierrez, M
Kotasek, D
Siddiqi, S
Chain, A
Butts, B D
Zhang, Y
Li, X
Cyrus, J
Tse, A
Altura, R A
Rasco, D
Abstract:
Is Part Of:: Annals of oncology. Volume 29(2018)Supplement 8
Journal:: Annals of oncology
Issue:: Volume 29(2018)Supplement 8
Issue Display:: Volume 29, Issue 8 (2018)
Year:: 2018
Volume:: 29
Issue:: 8
Issue Sort Value:: 2018-0029-0008-0000
Page Start:
Page End:
Publication Date:: 2018-10-23
Subjects:: Oncology -- Periodicals
616.992
Journal URLs:: https://www.journals.elsevier.com/annals-of-oncology ↗
http://ukcatalogue.oup.com/ ↗
DOI:: 10.1093/annonc/mdy279.402 ↗
Languages:: English
ISSNs:: 0923-7534
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 1043.320000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 12268.xml